↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "(WFRF:(Bosch J)) srt2:(2015-2019) srt2:(2019)"

Sökning: (WFRF:(Bosch J)) srt2:(2015-2019) > (2019)

Resultat 1-9 av 9

Sortera/gruppera träfflistan

Sortering: Träffar per sida:

Numrering	Referens	Omslagsbild	Hitta
1.	2019 Tidskriftsartikel (refereegranskat)
2.	Kehoe, Laura, et al. (författare) Make EU trade with Brazil sustainable 2019 Ingår i: Science. - : American Association for the Advancement of Science (AAAS). - 0036-8075 .- 1095-9203. ; 364:6438, s. 341- Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
3.	Moayyedi, P, et al. (författare) Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial 2019 Ingår i: Gastroenterology. - : Elsevier BV. - 1528-0012 .- 0016-5085. ; 157:2, s. 403- Tidskriftsartikel (refereegranskat)
4.	Moayyedi, P, et al. (författare) Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin 2019 Ingår i: Gastroenterology. - : Elsevier BV. - 1528-0012 .- 0016-5085. ; 157:3, s. 682- Tidskriftsartikel (refereegranskat)
5.	Bratman, Gregory N., et al. (författare) Nature and mental health : An ecosystem service perspective 2019 Ingår i: Science Advances. - : American Association for the Advancement of Science (AAAS). - 2375-2548. ; 5:7 Forskningsöversikt (refereegranskat)abstract A growing body of empirical evidence is revealing the value of nature experience for mental health. With rapid urbanization and declines in human contact with nature globally, crucial decisions must be made about how to preserve and enhance opportunities for nature experience. Here, we first provide points of consensus across the natural, social, and health sciences on the impacts of nature experience on cognitive functioning, emotional well-being, and other dimensions of mental health. We then show how ecosystem service assessments can be expanded to include mental health, and provide a heuristic, conceptual model for doing so.
6.	Eikelboom, JW, et al. (författare) Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis 2019 Ingår i: Circulation. - 1524-4539. ; 140:18, s. 1451-1459 Tidskriftsartikel (refereegranskat)
7.	Rozeman, EA, et al. (författare) Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial 2019 Ingår i: The Lancet. Oncology. - 1474-5488. ; 20:7, s. 948-960 Tidskriftsartikel (refereegranskat)
8.	Sharma, M, et al. (författare) Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial 2019 Ingår i: International journal of stroke : official journal of the International Stroke Society. - : SAGE Publications. - 1747-4949. ; 14:3, s. 270-281 Tidskriftsartikel (refereegranskat)abstract Covert vascular disease of the brain manifests as infarcts, white matter hyperintensities, and microbleeds on MRI. Their cumulative effect is often a decline in cognition, motor impairment, and psychiatric disorders. Preventive therapies for covert brain ischemia have not been established but represent a huge unmet clinical need. Aims The MRI substudy examines the effects of the antithrombotic regimens in COMPASS on incident covert brain infarcts (the primary outcome), white matter hyperintensities, and cognitive and functional status in a sample of consenting COMPASS participants without contraindications to MRI. Methods COMPASS is a randomized superiority trial testing rivaroxaban 2.5 mg bid plus acetylsalicylic acid 100 mg and rivaroxaban 5 mg bid against acetylsalicylic acid 100 mg per day for the combined endpoint of MI, stroke, and cardiovascular death in individuals with stable coronary artery disease or peripheral artery disease. T1-weighted, T2-weighted, T2*-weighted, and FLAIR images were obtained close to randomization and near the termination of assigned antithrombotic therapy; biomarker and genetic samples at randomization and one month, and cognitive and functional assessment at randomization, after two years and at the end of study. Results Between March 2013 and May 2016, 1905 participants were recruited from 86 centers in 16 countries. Of these participants, 1760 underwent baseline MRI scans that were deemed technically adequate for interpretation. The mean age at entry of participants with interpretable MRI was 71 years and 23.5% were women. Coronary artery disease was present in 90.4% and 28.1% had peripheral artery disease. Brain infarcts were present in 34.8%, 29.3% had cerebral microbleeds, and 93.0% had white matter hyperintensities. The median Montreal Cognitive Assessment score was 26 (interquartile range 23–28). Conclusions The COMPASS MRI substudy will examine the effect of the antithrombotic interventions on MRI-determined covert brain infarcts and cognition. Demonstration of a therapeutic effect of the antithrombotic regimens on brain infarcts would have implications for prevention of cognitive decline and provide insight into the pathogenesis of vascular cognitive decline.
9.	Heard, JM, et al. (författare) Research activity and capability in the European reference network MetabERN 2019 Ingår i: Orphanet journal of rare diseases. - : Springer Science and Business Media LLC. - 1750-1172. ; 14:1, s. 119- Tidskriftsartikel (refereegranskat)

Skapa referenser, mejla, bekava och länka

Länka till träfflistan

Resultat 1-9 av 9

Avgränsa träffmängd

Typ av publikation: tidskriftsartikel (8); forskningsöversikt (1)

Typ av innehåll: refereegranskat (8); övrigt vetenskapligt/konstnärligt (1)

Författare/redaktör: Zhu, J. (4); Rydén, L. (4); Yusuf, S. (4); Maggioni, AP (4); Diaz, R. (3); Liang, Y (3); visa fler...; Kim, JH (3); Kelly, Daniel (1); Hahn, A. (1); Bengtsson-Palme, Joh ... (1); Nilsson, Henrik (1); Aboyans, V (1); Yuan, F. (1); Kelly, Ryan (1); Li, Ying (1); Moore, Matthew D. (1); Rothhaupt, Karl-Otto (1); van Tinteren, H (1); Hansson, J. (1); Liu, Fang (1); Zhang, Yao (1); Jin, Yi (1); Raza, Ali (1); Rafiq, Muhammad (1); Zhang, Kai (1); Khatlani, T (1); Kahan, Thomas (1); Weigend, Maximilian (1); Eriksson, H (1); Müller, Jörg (1); Jones, S. (1); Sharma, M. (1); Farrell, Katharine N ... (1); Sörelius, Karl, 1981 ... (1); Gonzalez, M. (1); Batra, Jyotsna (1); Roobol, Monique J (1); Backman, Lars (1); Folke, Carl (1); Yan, Hong (1); Islar, Mine (1); Krause, Torsten (1); Uddling, Johan, 1972 (1); Alexanderson, Helena (1); Schneider, Christoph (1); Schmidt, Axel (1); Battiston, Roberto (1); Lorkowski, Stefan (1); Thrift, Amanda G. (1); Zhang, Wei (1); visa färre...

Lärosäte: Karolinska Institutet (7); Uppsala universitet (2); Stockholms universitet (2); Lunds universitet (2); Chalmers tekniska högskola (2); Göteborgs universitet (1); visa fler...; Kungliga Tekniska Högskolan (1); Högskolan i Halmstad (1); Mittuniversitetet (1); Sveriges Lantbruksuniversitet (1); visa färre...

Språk: Engelska (9)

Forskningsämne (UKÄ/SCB): Naturvetenskap (3); Medicin och hälsovetenskap (2); Teknik (1); Samhällsvetenskap (1)

År: 2019 (9)Ta bort avgränsningen

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - Nationella bibliotekssystem
LIBRIS.kb.se

pil uppåt

Stäng

Kopiera och spara länken för att återkomma till aktuell vy